Related Experiment Video
Updated: Dec 23, 2025
10:35
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
8.6K
Intravenous Immunoglobulin-Associated Hemolytic Anemia
Jeremy Jacobs1, Jessica Kneib1, Amy Gabbard1
1Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Laboratory Medicine
|April 28, 2020
Summary
Intravenous immunoglobulin (IVIG) can cause significant hemolytic anemia, even with moderate doses, particularly in patients with risk factors. This adverse effect requires increased clinical awareness during ITP treatment.
Area of Science:
- Immunology
- Hematology
Background:
- Intravenous immunoglobulin (IVIG) is a widely used therapeutic agent for various autoimmune and immune deficiency conditions.
- While generally well-tolerated, IVIG is associated with potential adverse effects, including hemolysis.
Observation:
- A case of significant hemolytic anemia requiring blood transfusion is presented in a 59-year-old woman treated with IVIG for immune thrombocytopenic purpura (ITP).
- Hemolytic complications from IVIG are often mild and incidentally detected via routine blood work.
Findings:
- This case highlights the potential for clinically significant hemolysis following moderate cumulative doses of IVIG.
- Risk factors for hemolysis should be considered in patients receiving IVIG therapy.
Implications:
- Increased clinical vigilance is necessary to recognize and manage IVIG-induced hemolysis.
- Early identification and intervention can prevent severe hemolytic anemia and its complications.
Related Concept Videos
01:25Immunodeficiency Diseases
1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.8K
02:45Blood Transfusion and Agglutination
13.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K
01:36Humoral Immune Responses
83.0K
Overview
83.0K
01:29Venous Thrombosis III: Interprofessional Care
211
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
211
01:15Transcytosis of IgG
3.9K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.9K